Author: Lynne Taylor

Seizures at European ports of generic drugs bound for developing nations have again been attacked by critics, who say the shipments are legal and accuse the European Union (EU) of double standards.

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has announced that trials in Sweden are now underway with a new system which aims to tackle the growing threat of counterfeit drugs.

The US Senate Judiciary Committee has voted 12-7 in favour of legislation to outlaw deals agreed between branded drugmakers and generics firms to delay the entry of generic competitors to the market.

Current Congressional plans to set up a regulatory pathway for generic biologic drugs would have no value, because the pathway they propose would scarcely be used, it is claimed.

After months of sometimes bitter wrangling, the US Senate Finance Committee yesterday approved the health reform bill drawn up by its chairman, Senator Max Baucus, with a 14-9 majority.